DC3 THERAPEUTICS

dc3-therapeutics-logo

DC3 Therapeutics is a full-service contract research organization. They offer a full set of services necessary for drug discovery, including pre-clinical and IND-enabling studies. Their services include histology and in vitro pharmacology, as well as molecular, cellular, and microbiology. And to ensure a quick turn-around time, each customer is assigned a secured DC3 account to conveniently download data, schedule pickup, and submit inquiries. Their team, which is committed to superior customer service, has extensive experience in the drug development process and the pharmaceutical industry. They offer a full set of services necessary for drug development.

#SimilarOrganizations #Website #More

DC3 THERAPEUTICS

Social Links:

Industry:
Biotechnology Consulting Pharmaceutical

Founded:
2014-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.dc3therapeutics.com

Total Employee:
11+

Status:
Active

Contact:
+1 415-594-9306

Email Addresses:
[email protected]


Similar Organizations

cri-the-clinical-research-institute-logo

CRI โ€“The Clinical Research Institute

CRI โ€“The Clinical Research Institute is a full-service Contract Research Organization for phase III and IV clinical trials.

Official Site Inspections

http://www.dc3therapeutics.com Semrush global rank: 5.76 M Semrush visits lastest month: 1.45 K

  • Host name: 199.60.103.198
  • IP address: 199.60.103.198
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "DC3 Therapeutics"

DC3 Therapeutics

DC3 Therapeutics, 163 West Harris Avenue, South San Francisco, CA, 94080, U.S. 415-594-9306 [email protected]See details»

DC3 Therapeutics - LinkedIn

DC3 Therapeutics is a full service Contract Research Organization (CRO). We offer a full set of services necessary for drug discovery, pre-clinical and IND enabling studies.See details»

DC3 Therapeutics - Crunchbase Company Profile & Funding

Contact Email [email protected]; Phone Number +1 415-594-9306; DC3 Therapeutics is a full-service contract research organization. They offer a full set of services โ€ฆSee details»

DC3 Therapeutics | Meso Scale Discovery

DC3 Therapeutics is a full service contract research organization, offering a full set of services necessary for drug development. We can support pre-clinical and IND enabling studies. Our โ€ฆSee details»

Contact Us - DC3 Therapeutics

DC3 Therapeutics, 163 West Harris Avenue, South San Francisco, CA, 94080, U.S. 415-594-9306 [email protected]See details»

DC3 Therapeutics, LLC โ€“ US Small Business Chamber of Commerce

DC3 Therapeutics is a full service Contract Research Organization (CRO). We offer a full set of services necessary for drug development. We can support Pre-Clinical and IND Enabling โ€ฆSee details»

DC3 Therapeutics, LLC - Biocom CRO

DC3 Therapeutics is a full-service CRO based in South San Francisco, CA. We provide standard and custom research solutions to biotech, pharma and research institutions across all stages of discovery and development through an โ€ฆSee details»

DC3 Therapeutics - VentureRadar

Smithers Viscient, Smithers Avanza USA n/a Smithers Viscient, formerly Smithers Springborn, is a global Contract Research Organization (CRO) for the crop protection, pharmaceutical, โ€ฆSee details»

DC3 Therapeutics - FedLinks

DC3 Therapeutics is a full service pre-clinical and clinical contract research organization (CRO). Our expertise is available to support and augment our clientsโ€™ laboratory operations and drug โ€ฆSee details»

DC3 Therapeutics - Overview, News & Competitors | ZoomInfo.com

View DC3 Therapeutics (www.dc3therapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

Dc3 Therapeutics LLC - Drug pipelines, Patents, Clinical trials

May 1, 2024 Explore Dc3 Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, .See details»

DC3 Therapeutics, LLC has secured $1,030,000.00 in

Feb 10, 2020 South San Francisco, CA โ€” DC3 Therapeutics, LLC has secured $1,030,000.00 in new commercial financing for expansion opportunities in South San Francisco. According to โ€ฆSee details»

DC3 Therapeutics Overview | SignalHire Company Profile

DC3 Therapeutics is a full service Contract Research Organization (CRO). We offer a full set of services necessary for drug discovery, pre-clinical and IND enabling studies. ... Organization โ€ฆSee details»

DC3 Therapeutics: Revenue, Worth, Valuation & Competitors 2024

About DC3 Therapeutics. DC3 Therapeutics is a Biotech related company founded in 2013 and based in San Francisco with an estimated revenue of $1.4M, and 9 employees. It has 10 โ€ฆSee details»

DC3 Therapeutics, LLC - CMOCRO

DC3 Therapeutics was founded as a provider of histology services. The company has since expanded its capabilities to include standard and custom research solutions for biotechnology โ€ฆSee details»

DC3 Therapeutics | South San Francisco CA - Facebook

Sep 17, 2015 DC3 Therapeutics, South San Francisco, California. 7 likes. DC3 Therapeutics is a full service Contract Research Organization (CRO). We offer a full set of services necessary โ€ฆSee details»

DC3 Therapeutics, LLC - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for DC3 Therapeutics, LLC of South San Francisco, CA. Get the latest business insights from Dun & โ€ฆSee details»

Dc3 Therapeutics LLC (Dc3 Therapeutics LLC) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ไธด โ€ฆ

SOUTH SAN FRANCISCO, Calif., and PARIS, June 6, 2022 --- Today at the Advances in Genome Biology and Technology (AGBT) Conference, DNA Script, a world leader in โ€ฆSee details»

Covid-19 Testing โ€” DC3 Therapeutics

Covid-19 testing. Available for: Workplace testing, individual testing, health care agencies, and community testing. We are offering COVID testing using both the molecular test and the โ€ฆSee details»

Novartis receives third FDA approval for oral Fabhalta® (iptacopan ...

Mar 21, 2025 Phase III study showed sustained proteinuria reduction at one year with favorable safety 1; Fabhalta is the only oral alternative complement pathway inhibitor thought to target โ€ฆSee details»

linkstock.net © 2022. All rights reserved